N. Mol. Nutr. Meals Res. 2006, 50, 53042. 22. Wu, Q.; Dohnal, V.; Huang, L.; Kuca, K.; Wang, X.; Chen, G.; Yuan, Z. Metabolic pathways of ochratoxin A. Curr. Drug Metab. 2011, 12, 10. 23. Manderville, R.A.; Pfohl-Leszkowicz, A. Bioactivation and DNA adduction as a rationale for ochratoxin A carcinogenesis. Globe Mycotoxin J. 2008, 1, 35767. 24. Tozlovanu, M.; Faucet-Marquis, V.; Pfohl-Leszkowicz, A.; Manderville, R.A. Genotoxicity in the hydroquinone metabolite of ochratoxin A: structure-activity relationships for covalent DNA adduction. Chem. Res. Toxicol. 2006, 19, 1241247. 25. Tozlovanu, M.; Canadas, D.; Pfohl-Leszkowicz, A.; Frenette, C.; Paugh, R.J.; Manderville, R.A. Glutathione conjugates of ochratoxin A as biomarkers of exposure. Arh. Hig. Rada. Toksikol. 2012, 63, 41727. 26. Jennings-Gee, J.E.; Tozlovanu, M.; Manderville, R.; Miller, M.S.; Pfohl-Leszkowicz, A.; Schwartz, G.G. Ochratoxin A: In utero exposure in mice induces adducts in testicular DNA. Toxins 2010, two, 1428444. 27. Maul, R.; Warth, B.; Kant, J.S.; Schebb, N.H.; Krska, R.; Koch, M.; Sulyok, M. Investigation with the hepatic glucuronidation pattern of the Fusarium mycotoxin deoxynivalenol in numerous species. Chem. Res. Toxicol. 2012, 25, 2715717. 28. Warth, B.; Sulyok, M.; Berthiller, F.; Schuhmacher, R.; Krska, R. New insights in to the human metabolism in the Fusarium mycotoxins deoxynivalenol and zearalenone. Toxicol. Lett. 2013, 220, 884. 29. Mikula, H.; Weber, J.; Lexmuller, S.; Bichl, G.; Schwartz, H.; Varga, E.; Berthiller, F.; Hametner, C.; Krska, R.; Frohlich, J. Simultaneous preparation of alpha/beta-zearalenol glucosides and glucuronides. Carbohydr. Res. 2013, 373, 593. 30. Shephard, G.S.; Burger, H.M.; Gambacorta, L.; Gong, Y.Y.; Krska, R.; Rheeder, J.P.; Solfrizzo, M.; Srey, C.; Sulyok, M.; Visconti, A.; et al. Various mycotoxin exposure determined by urinary biomarkers in rural subsistence farmers inside the former Transkei, South Africa. Meals Chem. Toxicol. 2013, 62, 21725.Toxins 2013,31. Warth, B.; Sulyok, M.; Fruhmann, P.; Mikula, H.; Berthiller, F.; Schuhmacher, R.; Hametner, C.; Abia, W.A.; Adam, G.; Frohlich, J.; et al. Improvement and validation of a fast multi-biomarker liquid chromatography/tandem mass spectrometry approach to assess human exposure to mycotoxins. Fast Commun. Mass Spectrom. 2012, 26, 1533540. 32. Li, S.; Marquardt, R.R.; Frohlich, A.A.; Vitti, T.G.; Crow, G. Pharmacokinetics of ochratoxin A and its metabolites in rats. Toxicol. Appl. Pharmacol. 1997, 145, 820. 33. Kuhn, I.; Valenta, H.; Rohr, K. Determination of ochratoxin A in bile of swine by high-performance liquid chromatography. J. Chromatogr. B 1995, 668, 33337. 34. Gross-Steinmeyer, K.; Weymann, J.; Hege, H.G.; Metzler, M. Metabolism and lack of DNA reactivity of your mycotoxin ochratoxin A in cultured rat and human major hepatocytes.Bethanechol chloride J.Dacarbazine Agric.PMID:26446225 Meals. Chem. 2002, 50, 93845. 35. Welsch, T.; Humpf, H.U. HT-2 Toxin 4-glucuronide as new T-2 toxin metabolite: Enzymatic synthesis, analysis, and species certain formation of T-2 and HT-2 toxin glucuronides by rat, mouse, pig, and human liver microsomes. J. Agric. Food. Chem. 2012, 60, 101700178. 36. Scapolla, C.; Cangemi, G.; Barco, S.; Barbagallo, L.; Bugnone, D.; Maffia, A.; Melioli, G.; Profumo, A.; Benatti, U.; Damonte, G. Identification and structural characterization by LC-ESI-IONTRAP and LC-ESI-TOF of some metabolic conjugation products of homovanillic acid in urine of neuroblastoma patients. J. Mass Spectrom. 2012, 47, 81624.
